Elekta AB (EKTAY)

Last Closing Price: --

Company Description

Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $1.71B
Net Income (Most Recent Fiscal Year) $122.52M
PE Ratio (Current Year Earnings Estimate) 13.23
PE Ratio (Trailing 12 Months) 18.93
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 1.24
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 2.14
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 8.89
Pre-Tax Margin (Trailing 12 Months) 7.46%
Net Margin (Trailing 12 Months) 1.15%
Return on Equity (Trailing 12 Months) 11.08%
Return on Assets (Trailing 12 Months) 3.66%
Current Ratio (Most Recent Fiscal Quarter) 1.06
Quick Ratio (Most Recent Fiscal Quarter) 0.83
Debt to Common Equity (Most Recent Fiscal Quarter) 0.58
Inventory Turnover (Trailing 12 Months) 3.40
Book Value per Share (Most Recent Fiscal Quarter) $2.64
Earnings per Share (Most Recent Fiscal Quarter) $0.11
Earnings per Share (Most Recent Fiscal Year) $0.29
Diluted Earnings per Share (Trailing 12 Months) $0.05
Stock
Exchange --
Sector --
Industry --
Common Shares Outstanding 383.57M
Free Float 225.23M
Market Capitalization $2.11B
Average Volume (Last 20 Days) 9075.90
Beta (Past 60 Months) 1.26
Percentage Held By Insiders (Latest Annual Proxy Report) 41.28%
Percentage Held By Institutions (Latest 13F Reports) 0.00%
Annual Dividend (Based on Last Quarter) $0.12
Dividend Yield (Based on Last Quarter) 2.16%